Summary

The trial code NASH-001 investigates melanoma in patients with diabetes from cancer trials in Poland sponsored by Pfizer. The study focuses on AZD0292, specifically a Phase 3 product phase 3 in France. The investigation aims to assess survival outcomes using the trial protocol number:2024-512345. This research is designed to evaluate the clinical efficacy and safety of the new melanoma treatment in this unique patient demographic.

Title

Clinical Trials Search - CTIS.eu

Description

Clinical Trials Search - CTIS.eu

Keywords

search, trials, cancer, condition, number, sponsor, protocol, title, product, filters, trial, field, fields, country, endpoint, sort, first

NS Lookup

A 172.67.169.15, A 104.21.27.76

Dates

Created 2026-04-13

Updated 2026-04-22

Summarized 2026-04-24